Once-daily dosing of aminoglycosides: Review and recommendations for clinical practice

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 677-686

  Freeman, Collin D ^a   Nicolau, David P ^b   Belliveau, Paul P ^c   Nightingale, Charles H ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; GENTAMICIN; NETILMICIN; TOBRAMYCIN;

BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; HUMAN; REVIEW;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; HUMANS; PRACTICE GUIDELINES;

EID: 0030754510     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.677     Document Type: Review

References (75)

1. Begg, E. J., Peddie, B. A., Chambers, S. T. & Boswell, D. R. (1992). Comparison of gentamicin dosing regimens using an invitro model. Journal of Antimicrobial Chemotherapy 29, 427-33.
2. MacArthur, R. D., Lolans, V., Zar, F. A. & Jackson, G. G. (1984). Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. Journal of Infectious Diseases 150, 778-9.
3. Jackson, G. G., Lolans, V. T. & Daikos, G. L. (1990). The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing. Journal of Infectious Diseases 162, 408-13.
4. Daikos, G. L., Jackson, G. G., Lolans, V. T. & Livermore, D. M. (1990). Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. Journal of Infectious Diseases 162, 414-20.
5. Drusano, G. L. (1988). Role of phamacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy 32, 289-97.
6. Deziel-Evans, L. M., Murphy, J. E. & Job, M. L. (1986). Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides. Clinical Pharmacy 5, 319-24.
7. Moore, R. D., Lietman, P. S. & Smith, C. R. (1987). Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. Journal of Infectious Diseases 155, 93-9.
8. Karlowsky, J. A., Zhanel, G. G., Davidson, R. J. & Hoban, D. J. (1994). Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 38, 1165-8.
9. Daikos, G. L., Lolans, V. T. & Jackson, G. G. (1991). First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrobial Agents and Chemotherapy 35, 117-23.
10. Gerber, A. U., Wiprachtiger, P., Stettler-Spichiger, U. & Lebek, G. (1982). Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro. Journal of Infectious Diseases 145, 554-60.
11. Gerber, A. U. (1988). Comparison of once-daily versus thrice-daily human equivalent dosing of aminoglycosides: basic considerations and experimental approach. Journal of Drug Development 1, Suppl. 3, 17-23.
12. Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J. & Craig, W. A. (1988). In vivo postantibiotic effect in a thigh infection in neutropenic mice. Journal of Infectious Diseases 157, 287-98.
13. McGrath, B. J., Lamp, K. C. & Rybak, M. J. (1993). Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model. Antimicrobial Agents and Chemotherapy 37, 1931-7.
14. Henry, N. K., Wilson, W. R. & Geraci, J. E. (1986). Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrobial Agents and Chemotherapy 30, 725-8.
15. Frazier, D. L. & Rivière, J. E. (1987). Gentamicin dosing strategies for dogs with subclinical renal dysfunction. Antimicrobial Agents and Chemotherapy 31, 1929-34.
16. Fantin, B., Pangon, B., Potel, G., Vallois, J. M., Caron, F., Bure, A. et al. (1989). Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrobial Agents and Chemotherapy 33, 767-70.
17. Fantin, B. & Carbon, C. (1990). Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrobial Agents and Chemotherapy 34, 2387-91.
18. Leggett, J. E., Ebert, S., Fantin, B. & Craig, W. A. (1990). Comparative dose-effect relations at several dosing intervals for beta-lactam, aminogiycoside and quinolone antibiotics against Gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian Journal of Infectious Diseases, Suppl. 74, 179-84.
19. Saleh-Mghir, A., Cremieux, A. C., Vallois, J. M., Muffat-Joly, M., Devine, C. & Carbon, C. (1992). Optimal aminoglycoside dosing regimen for penicillin-tobramcyin synergism in experimental Streptococcus adjacens endocarditis. Antimicrobial Agents and Chemotherapy 36, 2403-7.
20. Francioli, P. B. & Glauser, M. P. (1993). Synergystic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 37, 207-12.
21. Blatter, M., Fluckiger, U., Entenza, J., Glauser, M. P. & Francioli, P. (1993). Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 37, 1971-6.
22. Herscovici, L., Grise, G., Thauvin, C., Lemeland, J. F. & Fillastre, J. P. (1988). Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis. Scandinavian Journal of Infectious Diseases 20, 205-12.
23. Frame, P. T., Phair, J. P., Watanakunakorn, C. & Bannister, T. W. P. (1977). Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits. Journal of Infectious Diseases 135, 952-6.
24. Bennett, W. M., Plamp, C. E., Gilbert, D. N., Parker, R. A. & Porter, G. A. (1979). The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. Journal of Infectious Diseases 140, 576-80.
25. Tran Ba Huy, P., Bernard, P. & Schacht, J. (1986). Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. Journal of Clinical Investigation 77, 1492-500.
26. Kaloyanides, G. J. (1984). Renal pharmacology of aminoglycoside antibiotics. Contributions to Nephrology 42, 148-67.
27. Bennett, W. M., Wood, C. A., Houghton, D. C. & Gilbert, D. N. (1986). Modification of experimental aminoglycoside nephrotoxicity. American Journal of Kidney Diseases 8, 292-6.
28. Giuliano, R. A., Verpooten, G. A., Verbist, L., Wedeen, R. P. & De Broe, M. E. (1986). In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. Journal of Pharmacology and Experimental Therapeutics 236, 470-5.
29. Tran Ba Huy, P. & Deffrennes, D. (1988). Aminoglycoside ototoxicity: influence of dosage regimen on drug uptake and correlation between membrane binding and some clinical features. Acta Oto-Laryngologica (Stockholm) 105, 511-5.
30. Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D. et al. (1983). Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. Journal of Infectious Diseases 147, 918-32.
31. Moore, R. D., Smith, C. R. & Lietman, P. S. (1984). The association of aminoglycoside plasma levels with mortality in patients with Gram-negative bacteremia. Journal of Infectious Diseases 149, 443-8.
32. Moore, R. D., Smith, C. R. & Lietman, P. S. (1984). Association of aminoglycoside plasma levels with therapeutic outcome in Gram-negative pneumonia. American Journal of Medicine 77, 657-62.
33. Vreede, R. W. (1988). An open, randomized study of efficacy and safety of once-daily versus conventional dosing of netilmicin in combination-therapy in patients with severe infections. In Infections by Gram-negative Bacilli: Humoral Defence of the Host and Antimicrobial Therapy, pp. 143-65. Drukkerij Elinkwijk BV, Utrecht.
34. Nordström, L., Ringberg, H., Cronberg, S., Tjernström, O. & Walder, M. (1990). Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? Journal of Antimicrobial Chemotherapy 25, 159-73.
35. Labovitz, E., Levison, M. E. & Kaye, D. (1974). Single-dose daily gentamicin therapy in urinary tract infection. Antimicrobial Agents and Chemotherapy 6, 465-70.
36. Elhanan, K., Siplovich, L. & Raz, R. (1995). Gentamicin once-daily versus thrice-daily in children. Journal of Antimicrobial Chemotherapy 35, 327-32.
37. Fan, S. T., Lau, W. Y., Teoh-Chan, C. H., Lau, K. F. & Mauracher, E. H. (1988). Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis. Journal of Antimicrobial Chemotherapy 22, 69-74.
38. Mauracher, E. H., Lau, W. Y., Kartowisastro, H., Ong, K. H., Genato, V. X., Limson, B. et al. (1989). Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries. Clinical Therapeutics 11, 604-13.
39. Sturm, A. W. (1989). Netilmicin in the treatment of Gram-negative bacteremia: single daily versus multiple daily dosage. Journal of Infectious Diseases 159, 931-7.
40. Gilbert, D. N. (1991). Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy 35, 399-405.
41. Marik, P. E., Lipman, J., Kobilski, S. & Scribante, J. (1991). A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients. Journal of Antimicrobial Chemotherapy 28, 753-64.
42. Gibson, J., Johnson, L., Snowden, L., Joshua, D., Young, G., MacLeod, C. et al. (1993). Single daily ceftriaxone and tobramcyin in the empirical management of febrile neutropenic patients: a randomised trial. International Journal of Hematology 58, 63-72.
43. Bourget, P., Fernandez, H., Delouis, C. & Taburet, A. M. (1991). Pharmacokinetics of tobramycin in pregnant women. Safety and efficacy of a once-daily dose regimen. Journal of Clinical Pharmacy and Therapeutics 16, 167-76.
44. Valcke, Y. J., Vogelaers, D. P., Colardyn, F. A. & Pauwels, R. A. (1992). Penetration of netilmicin in the lower respiratory tract after once-daily dosing. Chest 101, 1028-32.
45. Prins, J. M., Buller, H. R., Kuijper, E. J., Tange, R. A. & Speelman, P. (1993). Once versus thrice daily gentamicin in patients with serious infections. Lancet 341, 335-9.
46. Raz, R., Adawi, M. & Romano, S. (1995). Intravenous administration of gentamicin once daily versus thrice daily in adults. European Journal of Clinical Microbiology and Infectious Diseases 14, 88-91.
47. Rozdzinski, E., Kern, W. V., Reichle, A., Moritz, T., Schmeiser, T., Gaus, W. et al. (1993). Once-daily versus thrice-daily dosing of netilmicin in combination with β-lactam antibiotics as empirical therapy with febrile neutropenic patients. Journal of Antimicrobial Chemotherapy 31, 585-98.
48. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. (1993). Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine 119, 584-93.
49. Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W. & Quintiliani, R. (1995). Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrobial Agents and Chemotherapy 39, 650-5.
50. Viscoli, C., Dudley, M., Ferrea, G., Boni, L., Castagnola, E., Barretta, M. A. et al. (1991). Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 113-20.
51. Meunier, F., Van der Auwera, P., Aoun, M., Ibrahim, S. & Tulkens, P. M. (1991). Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 129-39.
52. Viganò, A., Principi, N., Brivio, L., Tommasi, P., Stasi, P. & Villa, A. D. (1992). Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of Gram-negative pyelonephritis in children. Antimicrobial Agents and Chemotherapy 36, 1499-503.
53. Prins, J. M., Buller, H. R., Kuijper, E. J., Tange, R. A. & Speelman, P. (1994). Once-daily gentamicin versus once-daily netilmicin in patients with serious infections - a randomized clinical trial. Journal of Antimicrobial Chemotherapy 33, 823-35.
54. Skopnik, H. & Heimann, G. (1995). Once daily aminoglycoside dosing in full term neonates. Pediatric Infectious Diseases Journal 14, 71-2.
55. Francoli, P., Ruch, W., Stamboulian, D. & The International Infective Endocarditis Study Group. (1995). Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clinical Infectious Diseases 21, 1406-10.
56. Shankar, A. & Sharma, S. D. (1987). Gentamicin as once-daily dose therapy in recurrent urinary tract infections in children. Current Therapeutic Research 41, 599-603.
57. Belliveau, P. P., Nicolau, D. P., Nightingale, C. H. & Quintiliani, R. (1995). Once-daily gentamicin: experience in one hundred and eighteen patients with postpartum endometritis. Journal of Infectious Diseases Pharmacotherapy 1, 11-8.
58. Verpooten, G. A., Giuliano, R. A., Verbist, L., Eestermans, G. & De Broe, M. E. (1989). Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clinical Pharmacology and Therapeutics 45, 22-7.
59. Proctor, L., Petty, B., Thakor, R., Lietman, P., Glackin, R. & Shimuzu, H. (1987). A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycin. Laryngoscope 97, 1443-9.
60. Blaser, J., Simmen, H. P., Thurnheer, U., König, C. & Lüthy, R. (1995). Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections. Journal of Antimicrobial Chemotherapy 36, 803-14.
61. Reichley, R. M., Abraham, M., Little, J. R. & Bailey, T. C. (1995). Prospective evaluation of extended interval (El) aminoglycoside dosing at a 1200-bed institution (abstract A117). In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract A117, p. 22. American Society for Microbiology, Washington, DC.
62. Reichley, R. M., Little, J. R. & Bailey, T. C. (1995). Advantages of extended-interval aminoglycoside (AG) dosing in a predominantly elderly population. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract A118, p. 22. American Society for Microbiology, Washington, DC.
63. Tange, R. A., Dreschler, W. A., Prins, J. M., Büller, H. R., Kuijper, E. J. & Speelman, P. (1995). Ototoxicity and nephrotoxicity of gentamicin vs. netilmicin in patients with serious infections. A randomized clinical trial. Clinical Otolaryngology 20, 118-23.
64. Hatala, R., Dinh, T. & Cook, D. J. (1996). Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Annals of Internal Medicine 124, 717-25.
65. Munckhof, W. J., Grayson, M. L. & Turnidge, J. D. (1996). A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. Journal of Antimicrobial Chemotherapy 37, 645-63.
66. Ferriols-Lisart, R. & Alós-Almiñana, M. (1996). Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. American Journal of Health-System Pharmacy 53, 1141-50.
67. Petitti, D. B. (1994). Of babies and bathwater. American Journal of Epidemiology 140, 779-82.
68. MacGowan, A. P., Bedford, K. A., Blundell, E., Brown, N. M., Habib, F., Hows, J. et al. (1994). The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy. Journal of Antimicrobial Chemotherapy 34, 809-12.
69. Prins, J. M., Koopmans, R. P., Buller, H. R., Kuijper, E. J. & Speelman, P. (1995). Easier monitoring of aminoglycoside therapy with once-daily dosing schedules. European Journal of Clinical Microbiology and Infectious Diseases 14, 531-5.
70. Janknegt, R. (1993), Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation considered. Pharmacy World and Science 15, 151-5.
71. Blaser, J., Konig, C., Simmen, H.-P. & Thurnheer, U. (1994). Monitoring serum concentrations for once-daily netilmicin dosing regimens. Journal of Antimicrobial Chemotherapy 33, 341-8.
72. Begg, E. J., Barclay, M. L. & Duffull, S. B. (1995). A suggested approach to once-daily aminoglycoside dosing. British Journal of Clinical Pharmacology 39, 605-9.
73. Barclay, M. L., Duffull, S. B., Begg, E. J. & Buttimore, R. C. (1995). Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve. Australian and New Zealand Journal of Medicine 25, 230-5.
74. Nicolau, D. P., Wu, A. H. B., Finocchiaro, S., Udeh, E., Chow, M. S. S., Quintiliani, R. et al. (1996). Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Therapeutic Drug Monitoring 18, 263-6.
75. Parker, S. E. & Davey, P. G. (1995). Once-daily aminoglycoside administration in Gram-negative sepsis: economic and practical aspects. Pharmacoeconomics 7, 393-402.